Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 110 of 156 found articles
 
 
  Phase III randomized trial of volasertib combined with low-dose cytarabine (LDAC) versus placebo plus LDAC in patients aged ≥65 years with previously untreated, acute myeloid leukemia (AML) ineligible for intensive remission induction therapy
 
 
Title: Phase III randomized trial of volasertib combined with low-dose cytarabine (LDAC) versus placebo plus LDAC in patients aged ≥65 years with previously untreated, acute myeloid leukemia (AML) ineligible for intensive remission induction therapy
Author: DeAngelo, Daniel J.
Sekeres, Mikkael A.
Ottmann, Oliver G.
Sanz, Miguel A.
Naoe, Tomoki
Taube, Tillmann
Belsack, Valerie
Ge, Miaomiao
Döhner, Hartmut
Appeared in: Clinical lymphoma myeloma and leukemia
Paging: Volume 15 (2015) nr. S pages 1 p.
Year: 2015
Contents:
Publisher: Published by Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 110 of 156 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands